期刊
JOURNAL OF EXPERIMENTAL MEDICINE
卷 208, 期 7, 页码 1523-1531出版社
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20101167
关键词
-
资金
- Science Foundation Ireland [07/IN1/B902]
- National Children's Research Centre
- Department for Employment and Learning of Northern Ireland
- Welcome Trust [WT008532]
- Health Research Board (Ireland) [PD12008/01]
- MRC (UK) [G1001795]
- MRC [G1001795] Funding Source: UKRI
- Medical Research Council [G1001795] Funding Source: researchfish
- Public Health Agency [EAT/3730/07] Funding Source: researchfish
The incidence of allergy and asthma in developed countries is on the increase and this trend looks likely to continue. CD4(+) T helper 2 (Th2) cells are major drivers of these diseases and their commitment is controlled by cytokines such as interleukin 4, which are in turn regulated by the suppressor of cytokine signaling (SOCS) proteins. We report that SOCS2(-/-) CD4(+) T cells show markedly enhanced Th2 differentiation. SOCS2(-/-) mice, as well as RAG1(-/-) mice transferred with SOCS2(-/-) CD4(+) T cells, exhibit elevated type 2 responses after helminth antigen challenge. Moreover, in in vivo models of atopic dermatitis and allergen-induced airway inflammation, SOCS2(-/-) mice show significantly elevated IgE, eosinophilia, type 2 responses, and inflammatory pathology relative to wild-type mice. Finally, after T cell activation, markedly enhanced STAT6 and STAT5 phosphorylation is observed in SOCS2(-/-) T cells, whereas STAT3 phosphorylation is blunted. Thus, we provide the first evidence that SOCS2 plays an important role in regulating Th2 cell expansion and development of the type 2 allergic responses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据